These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18238944)

  • 41. Too late, again?
    Jones NL
    Can Respir J; 2001; 8(3):127-8. PubMed ID: 11420587
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study.
    Maréchaux S; Jeu A; Jobic Y; Ederhy S; Donal E; Réant P; Abouth S; Arnasteen E; Boulanger J; Ennezat PV; Garban T; Szymanski C; Tribouilloy C
    Arch Cardiovasc Dis; 2013; 106(6-7):349-56. PubMed ID: 23876809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complex vascular lesions at autopsy in a patient with phentermine-fenfluramine use and rapidly progressing pulmonary hypertension.
    Strother J; Fedullo P; Yi ES; Masliah E
    Arch Pathol Lab Med; 1999 Jun; 123(6):539-40. PubMed ID: 10383810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benfluorex: the last chapter of drug-induced valvular heart disease?
    Droogmans S; Cosyns B; Van Camp G
    Eur J Echocardiogr; 2011 Apr; 12(4):263-4. PubMed ID: 21193483
    [No Abstract]   [Full Text] [Related]  

  • 45. The longitudinal effects of fenfluramine-phentermine use.
    Fleming RM; Boyd LB
    Angiology; 2007; 58(3):353-9. PubMed ID: 17626991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
    Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435
    [No Abstract]   [Full Text] [Related]  

  • 47. High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine.
    Davis WM; Waters IW
    Med Hypotheses; 1997 Dec; 49(6):509-12. PubMed ID: 9466375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unusual hypotension and bradycardia in a patient receiving fenfluramine, phentermine, and fluoxetine.
    Rich JM; Njo L; Roberts KW; Smith KP
    Anesthesiology; 1998 Feb; 88(2):529-31. PubMed ID: 9477076
    [No Abstract]   [Full Text] [Related]  

  • 49. Fen-phen's message to dentists.
    Hilsen K; Davis S; Iyer P
    J N J Dent Assoc; 1998; 69(1):37, 47. PubMed ID: 9584764
    [No Abstract]   [Full Text] [Related]  

  • 50. After fen-phen/Redux: cardiac and pulmonary sequelae implications for patient assessment.
    Brown-Beasley MW
    J Emerg Nurs; 1998 Feb; 24(1):62-5. PubMed ID: 9534536
    [No Abstract]   [Full Text] [Related]  

  • 51. Fenfluramine-like cardiovascular side-effects of benfluorex.
    Boutet K; Frachon I; Jobic Y; Gut-Gobert C; Leroyer C; Carlhant-Kowalski D; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2009 Mar; 33(3):684-8. PubMed ID: 19251806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Appetite-suppressant drugs and primary pulmonary hypertension.
    Fishman AP
    N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650
    [No Abstract]   [Full Text] [Related]  

  • 53. Benfluorex: how many deaths?
    Prescrire Int; 2011 Feb; 20(113):45. PubMed ID: 21488593
    [No Abstract]   [Full Text] [Related]  

  • 54. Obesity and an abnormal ECG.
    Hancock EW
    Hosp Pract (1995); 1997 Sep; 32(9):19-20. PubMed ID: 9307592
    [No Abstract]   [Full Text] [Related]  

  • 55. Diet drugs and pulmonary hypertension.
    Havron MD
    J Fam Pract; 1996 Nov; 43(5):434-5. PubMed ID: 8917134
    [No Abstract]   [Full Text] [Related]  

  • 56. Relearning the lessons of history: anorexigens and pulmonary hypertension.
    Langleben D
    Chest; 1998 Jul; 114(1 Suppl):55S-57S. PubMed ID: 9676629
    [No Abstract]   [Full Text] [Related]  

  • 57. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.
    Rich S; Rubin L; Walker AM; Schneeweiss S; Abenhaim L
    Chest; 2000 Mar; 117(3):870-4. PubMed ID: 10713017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitral valve disease associated with use of anorexigenic medications.
    Cheng TO
    Ann Thorac Surg; 1998 Jan; 65(1):298-9. PubMed ID: 9456151
    [No Abstract]   [Full Text] [Related]  

  • 59. The serotonergic appetite suppressant fenfluramine. Reappraisal and rejection.
    Curzon G; Gibson EL
    Adv Exp Med Biol; 1999; 467():95-100. PubMed ID: 10721044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.
    Teramae CY; Connolly HM; Grogan M; Miller FA
    Mayo Clin Proc; 2000 May; 75(5):456-61. PubMed ID: 10807073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.